跳到正文
原文
Adam Feuerstein ✡️· @adamfeuerstein · X·· 11 天前AI 评分20
AI 导读

STAT记者Adam Feuerstein表示,他比以往更确信FDA将在月底拒绝Capricor的细胞疗法deramiocel。其理由是,若审评进展顺利且Capricor对获批有信心,Craig McDonald博士不会在PDUFA日期前一个月公开提交给FDA的信函;他认为Capricor公开此信正是因其申请陷入困境,试图借此向FDA施加公众压力以改变决定。

正文

$CAPR I am more convinced than ever the FDA is going to reject deramiocel at the end of the month.

Why?

Because if all was going well with the review, and Capricor was confident the FDA was going to approve its cell therapy, Dr. Craig McDonald would not have publicly posted this letter submitted to the FDA — one month before the PDUFA date.

http://lnkd.in/p/gCCH65Mk

The only reason McDonald made this letter public was because Capricor knows its application is in trouble, therefore it is trying to apply more public pressure to get the FDA to change its mind.

来源:Adam Feuerstein ✡️ · x.com